F11.151

Clinical Causes: Prolonged or excessive opioid use leading to neurochemical imbalances in the brain High doses of opioid intake that overwhelm the brain's normal functioning Co-occurring mental health disorders that increase vulnerability to psychotic symptoms History of substance abuse with frequent or chronic use patterns Genetic factors that may predispose individuals to psychosis in response to opioid use

Key Symptoms: Hallucinations, often visual or auditory, where the individual perceives things that are not present Altered perception of reality, including paranoid thoughts or delusional beliefs Confusion or disorganized thinking Agitation or severe restlessness Changes in behavior, such as withdrawal from social activities or sudden mood swings

Diagnosis Path: Diagnosis involves a thorough clinical assessment by a healthcare professional, including a detailed medical history, a physical and neurological examination, and mental health evaluation. Additional assessments like urine toxicology tests help confirm opioid use. Differential diagnosis may be necessary to distinguish between primary psychotic disorders and substance-induced psychosis. The clinician assesses whether the psychotic symptoms occur during or shortly after substance use and whether they resolve with abstinence.

Treatment Protocols: Medical detoxification to safely manage withdrawal symptoms Medication-assisted therapy (MAT), such as methadone or buprenorphine, to reduce opioid cravings Antipsychotic medications to control hallucinations and other psychotic symptoms Psychotherapy options like cognitive-behavioral therapy (CBT) to address substance abuse behaviors and underlying mental health issues Support groups and counseling to promote long-term recovery and prevent relapse Monitoring for potential side effects of medications and ongoing assessment of mental health status